Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2
- 1 March 1999
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 13 (4) , 455-463
- https://doi.org/10.1097/00002030-199903110-00003
Abstract
The treatment of HIV-infected patients with interleukin (IL)-2 causes a sustained increase in CD4+ T-lymphocyte counts, involving both naive and memory cells. However, the short-term immunological effects of IL-2, which may shed light on the mechanism of immune reconstitution by this cytokine, are unknown. To evaluate the acute effect of IL-2 on circulating T-lymphocyte subpopulations and their expression of chemokine receptors. Flow cytometry, reverse transcriptase polymerase chain reaction and chemokine receptor function experiments were performed before and after 5 days of IL-2 administration in 30 HIV-infected patients. IL-2 induced an acute lymphopenia of both naive and memory T-helper (TH) lymphocytes. This was associated with a large increase in CC-chemokine receptor (CCR)-5 and CCR-2b expression by TH cells. Before IL-2 treatment, CCR-5 was mostly produced by CD62L- memory TH lymphocytes. After 5 days of IL-2 administration, the level of CCR-5 mRNA in circulating cells was 18.6 times higher than before treatment (P < 0.002). CCR-5 expression was upregulated in CD62L- memory TH lymphocytes, but also in CD62L+ memory and in naive (CD62L+ CD45RO-) TH lymphocytes. IL-2 treatment also increased the function of CCR-5 in TH cells. Chemokine receptors are involved in trafficking of lymphocytes. The IL-2-induced upregulation of chemokine receptors in TH cells may thus play a role in the acute effects of this cytokine in TH lymphocyte redistribution.Keywords
This publication has 22 references indexed in Scilit:
- CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In VitroThe Journal of Experimental Medicine, 1997
- The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytesProceedings of the National Academy of Sciences, 1997
- Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1996
- Expression of L‐selectin (CD62L) discriminates Th1‐ and Th2‐like cytokine‐producing memory CD4+ T cellsImmunology, 1996
- Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.Proceedings of the National Academy of Sciences, 1995
- Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.Proceedings of the National Academy of Sciences, 1995
- Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary StudyNew England Journal of Medicine, 1995
- Long-Term Effects Of Interleukin-2 On Cd4 Cell Counts In Human Immunodeficiency Virus-Infected PatientsThe Journal of Infectious Diseases, 1994
- A Phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudineAIDS, 1994
- Chemotactic peptide modulation of actin assembly and locomotion in neutrophils.The Journal of cell biology, 1984